NASDAQ (usa) |
![]() |
6715.56 | -12.11 | -0.18% |
FTSE 100 (london) |
![]() |
7487.96 | -5.12 | -0.07% |
DAX (german) |
![]() |
13465.51 | 235.94 | 1.78% |
NIKKEI 225 (japan) |
![]() |
22420.08 | 408.47 | 1.86% |
Hang - Seng (hong kong) |
![]() |
28594.06 | 348.52 | 1.23% |
NIFTY - 50 (india) | ||||
Straits Times (singapore) |
![]() |
3391.61 | 17.53 | 0.52% |
KOSPI (korea) |
![]() |
2556.47 | 33.04 | 1.31% |
All Ordinaries (australia) |
![]() |
6005.30 | 28.90 | 0.48% |
BOVESPA (brazil) |
![]() |
74092.76 | -215.73 | -0.29% |
Insmed Inc. (LSE: 0JAV)
0JAV Technical Analysis
5
As on 12th Nov 2024 0JAV STOCK Price closed @ 70.40 and we RECOMMEND Strong Buy for LONG-TERM with Stoploss of 24.55 & Strong Buy for SHORT-TERM with Stoploss of 22.05 we also expect STOCK to react on Following IMPORTANT LEVELS. |
0JAVSTOCK Price
Open | 71.28 | Change | Price | % |
High | 71.82 | 1 Day | -1.82 | -2.52 |
Low | 70.07 | 1 Week | 2.17 | 3.18 |
Close | 70.40 | 1 Month | -1.53 | -2.13 |
Volume | 2324 | 1 Year | 43.40 | 160.74 |
52 Week High 79.99 | 52 Week Low 16.75 |
LSE UK Most Active Stocks
ORCP | 0.02 | 0.00% |
SYME | 0.00 | % |
MSMN | 0.04 | 0.00% |
GFIN | 0.09 | -10.00% |
SMDS | 582.50 | 0.00% |
DKE | 0.15 | 0.00% |
SRC | 76.90 | 9.23% |
NNN | 0.09 | 50.00% |
VOD | 68.00 | 2.66% |
GWMO | 0.01 | 0.00% |
LSE UK Top Gainers Stocks
LSE UK Top Losers Stocks
0JAV Daily Charts |
0JAV Intraday Charts |
Whats New @ Bazaartrend |
0JAV Free Analysis |
|
0JAV Important Levels Intraday
RESISTANCE | 73.77 |
RESISTANCE | 72.69 |
RESISTANCE | 72.02 |
RESISTANCE | 71.35 |
SUPPORT | 69.45 |
SUPPORT | 68.78 |
SUPPORT | 68.11 |
SUPPORT | 67.03 |
0JAV Forecast February 2025
4th UP Forecast | 93.52 |
3rd UP Forecast | 86.11 |
2nd UP Forecast | 81.52 |
1st UP Forecast | 76.94 |
1st DOWN Forecast | 63.86 |
2nd DOWN Forecast | 59.28 |
3rd DOWN Forecast | 54.69 |
4th DOWN Forecast | 47.28 |
0JAV Weekly Forecast
4th UP Forecast | 79.53 |
3rd UP Forecast | 76.60 |
2nd UP Forecast | 74.79 |
1st UP Forecast | 72.98 |
1st DOWN Forecast | 67.82 |
2nd DOWN Forecast | 66.01 |
3rd DOWN Forecast | 64.20 |
4th DOWN Forecast | 61.27 |
0JAV Forecast2025
4th UP Forecast | 192.69 |
3rd UP Forecast | 153.47 |
2nd UP Forecast | 129.23 |
1st UP Forecast | 104.99 |
1st DOWN Forecast | 35.81 |
2nd DOWN Forecast | 11.57 |
3rd DOWN Forecast | -12.67 |
4th DOWN Forecast | -51.89 |
Insmed Inc. ( LSE UK Symbol : 0JAV )
Sector : N/A And Other Stocks in Same Sector
Sector : N/A And Other Stocks in Same Sector
0JAV Other Details
Segment | EQ | |
Market Capital | 2412195584.00 | |
Sector | ||
Industry | ||
Offical website | > echo $website ; ?> |
0JAV Address
![]() |
0JAV Latest News
0JAV Business Profile
Insmed Incorporated, a biopharmaceutical company, develops and commercializes therapies for patients with serious and rare diseases. The company offers ARIKAYCE for the treatment of Mycobacterium avium complex lung disease as part of a combination antibacterial drug regimen for adult patients. It is also developing Brensocatib, an oral reversible inhibitor of dipeptidyl peptidase 1 for the treatment of patients with bronchiectasis and other neutrophil-mediated diseases; and Treprostinil Palmitil Inhalation Powder, an inhaled formulation of a treprostinil prodrug treprostinil palmitil for the treatment of pulmonary arterial hypertension and other rare pulmonary disorders. The company was founded in 1988 and is headquartered in Bridgewater, New Jersey. Address: 700 US Highway 202/206, Bridgewater, NJ, United States, 08807-1704
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service